Can you provide the average price target for EXPONENT INC stock?
10 analysts have analysed EXPO and the average price target is 89.25 USD. This implies a price increase of 33.71% is expected in the next year compared to the current price of 66.75.
EXPONENT INC (EXPO) Forecast, Price Target & Analyst Ratings
NASDAQ:EXPO • US30214U1025
Current stock price
66.75 USD
+0.95 (+1.44%)
At close:
66.75 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EXPONENT INC (EXPO).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 23, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.58
- Revenue Estimate
- 156.09M
Price Target Details & History
Consensus Price Target and Range
Mean target
$89.25
Upside
+ 33.71%
From current price of $66.75 to mean target of $89.25, Based on 10 analyst forecasts
Low
$85.85
Median
$89.25
High
$94.50
Price Target Revisions
1 Month
0.00%
3 Months
2.34%
Price Target Summary
10 Wall Street analysts provided a forecast for the next 12 months for EXPO. The average price target is 89.25 USD. This implies a price increase of 33.71% is expected in the next year compared to the current price of 66.75.
The average price target has been revised upward by 2.34% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.00%
EXPO was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about EXPO.
In the previous month the buy percentage consensus was at a similar level.
EXPO was analyzed by 10 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-26 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-26 | JP Morgan | Initiate | Overweight |
| 2025-12-15 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-17 | William Blair | Upgrade | Market Perform -> Outperform |
| 2024-07-26 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-04-29 | Truist Securities | Maintains | Buy -> Buy |
| 2024-02-02 | Truist Securities | Maintains | Buy -> Buy |
| 2023-07-31 | Truist Securities | Maintains | Buy -> Buy |
| 2023-06-01 | UBS | Initiate | Neutral |
| 2021-08-02 | Truist Securities | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 23, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.58
- Revenue Estimate
- 156.09M
- Revenue Q2Q
- 13.57%
- EPS Q2Q
- 11.32%
- Number of Analysts
- 6
Next Earnings Revisions
Revenue (1 Month)
0.66%
Revenue (3 Months)
5.92%
EPS (1 Month)
-1.73%
EPS (3 Months)
3.81%
Next Earnings Summary
EXPO is expected to report earnings on 4/23/2026. The consensus EPS estimate for the next earnings is 0.58 USD and the consensus revenue estimate is 156.09M USD.
The next earnings revenue estimate has been revised upward by 5.92% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2026 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 536.766M 4.57% | 558.514M 4.05% | 582.014M 4.21% | 605.19M 3.98% | 656.61M 8.50% | 676.38M 3.01% | |
| EBITDA YoY % growth | 120.238M -18.71% | 129.246M 7.49% | 129.87M 0.48% | 179.62M 38.31% | 196.54M 9.42% | 195.19M -0.69% | |
| EBIT YoY % growth | 111.322M -20.96% | 119.557M 7.40% | 119.787M 0.19% | 154.26M 28.78% | 171.12M 10.93% | 183.22M 7.07% | |
| Operating Margin | 20.74% | 21.41% | 20.58% | 25.49% | 26.06% | 27.09% | |
| EPS YoY % growth | 1.95 -0.51% | 2.12 8.72% | 2.08 -1.89% | 2.32 11.32% | 2.57 10.79% | 2.72 6.16% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.58 11.32% | 0.58 12.30% | 0.60 9.88% | 0.54 9.81% | 0.63 8.37% | 0.65 11.79% | 0.67 11.39% | 0.60 10.90% |
| Revenue Q2Q % growth | 156.09M 13.57% | 150.62M 13.36% | 153.57M 12.04% | 149.03M 15.19% | 161.16M 3.25% | 160.14M 6.32% | 160.14M 4.28% | 151.98M 1.98% |
| EBITDA Q2Q % growth | 48.902M 4.22% | 45.706M 105.98% | 46.648M 27.52% | 42.517M 8.40% | 52.02M 6.38% | 53.04M 16.05% | 53.04M 13.70% | 47.94M 12.75% |
| EBIT Q2Q % growth | 40.131M -9.68% | 38.584M 124.63% | 40.129M 38.19% | 35.464M 21.70% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
9.40%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
7.39%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
16.08%
EBIT Next 5 Year
N/A
EXPONENT INC / EXPO Forecast FAQ
When does EXPONENT INC (EXPO) report earnings?
EXPONENT INC (EXPO) will report earnings on 2026-04-23.
What are the consensus estimates for EXPO stock next earnings?
The consensus EPS estimate for the next earnings of EXPONENT INC (EXPO) is 0.58 USD and the consensus revenue estimate is 156.09M USD.
Can you provide the consensus rating for EXPONENT INC stock?
The consensus rating for EXPONENT INC (EXPO) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.